Keros Therapeutics (KROS) PT Lowered to $25 at Truist Securities
Tweet Send to a Friend
(Updated - April 9, 2025 9:34 AM EDT)
Truist Securities analyst Srikripa Devarakonda lowered the price target on Keros ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Truist Securities analyst Srikripa Devarakonda lowered the price target on Keros ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
